A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
National Cancer Institute (NCI)
Eli Lilly and Company
OncoC4, Inc.
Seagen Inc.
KaliVir Immunotherapeutics
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Eli Lilly and Company
SystImmune Inc.
Rondo Therapeutics
Orano Med LLC
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
Alterome Therapeutics, Inc.
ViroMissile, Inc.
Tizona Therapeutics, Inc
Jonsson Comprehensive Cancer Center
MacroGenics
Innate Pharma
Dren Bio
OncoNano Medicine, Inc.
City of Hope Medical Center
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Nurix Therapeutics, Inc.
Pfizer
Jonsson Comprehensive Cancer Center
University of Virginia
Incyte Corporation
NextPoint Therapeutics, Inc.
Zhejiang University
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Seagen Inc.
Seagen Inc.
Vincerx Pharma, Inc.
AstraZeneca
Molecular Templates, Inc.
NGM Biopharmaceuticals, Inc
The Affiliated Hospital of Qingdao University
Xencor, Inc.
Gene Surgery LLC
Pliant Therapeutics, Inc.
Zhejiang University
NGM Biopharmaceuticals, Inc
HRYZ Biotech Co.
HRYZ Biotech Co.